Cargando…
Antithrombin effect on coagulation and fibrinolytic profiles after living donor liver transplantation: a pilot study
Early after liver transplantation, patients are in a hypercoagulable state because of an imbalance between coagulation and fibrinolysis because of the slow recovery of depleted anticoagulant proteins. Antithrombin (AT) is used in anticoagulant protocols to prevent thrombosis. The subjects of the pre...
Autores principales: | KANEKO, J, SUGAWARA, Y, TAMURA, S, TOGASHI, J, MATSUI, Y, MAKUUCHI, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002043/ https://www.ncbi.nlm.nih.gov/pubmed/18727651 http://dx.doi.org/10.1111/j.1751-553X.2007.01008.x |
Ejemplares similares
-
Acquisition of methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a retrospective cohort study
por: Hashimoto, Masao, et al.
Publicado: (2008) -
Impact of Donor and Recipient Single Nucleotide Polymorphisms of IL28B rs8099917 in Living Donor Liver Transplantation for Hepatitis C
por: Harada, Nobuhiro, et al.
Publicado: (2014) -
Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft
por: Aoki, Taku, et al.
Publicado: (2012) -
Antithrombin III treatment for portal vein thrombosis after living donor liver transplantation: a case report
por: Hirata, Yuta, et al.
Publicado: (2020) -
Living-Donor Liver Transplantation and Hepatitis C
por: Akamatsu, Nobuhisa, et al.
Publicado: (2013)